AGBA Group Holding Limited (納斯達克編號:AGBA) 宣布股份回購計劃

AGBA Group Holding Limited (納斯達克編號:AGBA) 宣布股份回購計劃

香港2023年4月18日 /美通社/ — 納斯達克上市公司AGBA Group Holding Limited(「AGBA」「匯邦」)是香港領先的一站式金融超市,董事會今天宣布批准一項股份回購計劃,授權以不超過10,000,000美元回購最多1,000,000股AGBA普通股。回購反映AGBA致力回饋股東,為他們帶來價值,同時保持財務靈活性,以投資高增長機會。回購計劃亦顯示董事會對公司未來前景充滿信心。

AGBA集團總裁吳榮輝表示:「AGBA注重創造和捍衛股東利益。公司的龐大規模,加上雄厚的業務實力以及中國重新開關所帶來的巨大機遇,讓我們能夠繼續進行長期投資,同時藉回購計劃回購公司股票。回購計劃明確反映我們認為AGBA目前估值被嚴重低估,並表明我們對業務和未來的商機充滿信心。」

按適用的證券法例及監管規定,AGBA或會不時在公開市場回購股份。公開市場回購將根據經修訂的1934年證券交易法(「交易法」)第10b-18條進行。

任何股份回購的方式、時間和金額將由AGBA管理層根據其對普通股交易價格、市場和經濟狀況、監管要求和其他公司考慮因素等,作出評估及自行決定。

有關授權於2024年4月18日到期,並可能隨時暫停或終止。公司亦沒有義務回購任何數量的普通股。

Safe Harbor Statement

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company’s goals and strategies; the Company’s future business development; product and service demand and acceptance; changes in technology; economic conditions; the outcome of any legal proceedings that may be instituted against us following the consummation of the business combination; expectations regarding our strategies and future financial performance, including its future business plans or objectives, prospective performance and opportunities and competitors, revenues, products, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures, and our ability to invest in growth initiatives and pursue acquisition opportunities; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Hong Kong and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC, the length and severity of the recent coronavirus outbreak, including its impacts across our business and operations. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward–looking statements to reflect events or circumstances that arise after the date hereof.

關於AGBA集團

AGBA集團(納斯達克:「AGBA」)成立於1993年,是一家以香港為基地的領先一站式金融超市,在粵港澳大灣區提供最廣泛的金融和醫療保健服務,通過以技術為主導的生態系統,讓客戶能夠選擇最適合他們需求的方案。AGBA擁有四大業務:平台業務、分銷業務、醫療保健業務和金融科技業務,均領先市場,深受超過400,000名個人和企業客戶的信賴。

如欲了解AGBA更多資料,請瀏覽AGBA網站:www.agba.com

社交媒體:

agbagroup

LinkedIn | Twitter | Instagram | Facebook | YouTube

 

 

 

醫療信箱

多謝醫生

張國良醫生

張國良醫生(婦產科): 仁心仁術。價格相...

劉偉文醫生

劉偉文醫生(牙科): 細心,價格合理 k...

吳蓬盛醫生

吳蓬盛醫生(精神科): 他是一位好有醫德...

更多資訊

臨床腫瘤科專科李宇聰醫生 結合治療是免疫的王道